Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1988-06-02
1989-12-05
Springer, David B.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548542, C07D20738, A61K 3140
Patent
active
048853062
ABSTRACT:
Compounds useful in the treatment of patients suffering from intellectual or nervous asthenias, memory failures, senescence or mental strain of the formula (I) ##STR1## in which R' and R.sub.2, being identical or different, represent hydrogen, a linear, branched or cyclic alkyl containing up to 8 carbon atoms, alkenyl containing from 2 to 8 carbon atoms, acyl containing from 1 to 6 carbon atoms or aralkyl containing from 7 to 15 carbon atoms, R.sub.1 represents a possibly substituted aryl containing up to 14 carbon atoms, or a possibly substituted mono- or polycyclic heterocyclic aromatic radical; also therapeutic compositions containing those compounds and method of use.
REFERENCES:
patent: 3117975 (1964-01-01), Bortnick et al.
patent: 3423426 (1969-01-01), Kohn
patent: 3686169 (1972-08-01), Coran et al.
Drugs of the Future, vol. 10, No. 12, 1985, pp. 972, 974.
Barzaghi Fernando
Galliani Giulio
Gorini Carlo
Toja Emilio
Roussel Uclaf
Springer David B.
LandOfFree
Derivatives of 1-arylsulphonyl-2-oxo-5-alkoxy-pyrrolidine and me does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Derivatives of 1-arylsulphonyl-2-oxo-5-alkoxy-pyrrolidine and me, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Derivatives of 1-arylsulphonyl-2-oxo-5-alkoxy-pyrrolidine and me will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2034696